List of Topicort drug patents

Topicort is owned by Taro Pharms.

Topicort contains Desoximetasone.

Topicort has a total of 2 drug patents out of which 0 drug patents have expired.

Topicort was authorised for market use on 11 April, 2013.

Topicort is available in spray;topical dosage forms.

Topicort can be used as treatment of plaque psoriasis in patients 18 years of age or older.

The generics of Topicort are possible to be released after 01 September, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8715624 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
May, 2026

(3 years from now)

US8277780 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
Sep, 2028

(5 years from now)

Drugs and Companies using DESOXIMETASONE ingredient

Market Authorisation Date: 11 April, 2013

Treatment: Treatment of plaque psoriasis in patients 18 years of age or older

Dosage: SPRAY;TOPICAL

How can I launch a generic of TOPICORT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in